{
  "id": "c31f95b1-e455-4c76-8d48-ab0e0612eaea",
  "title": "Sanofi to buy Vigil Neuroscience in $470M deal, adding Alzheimer’s treatment to pipeline",
  "link": "https://seekingalpha.com/news/4451341-sanofi-to-buy-vigil-neuroscience-in-470m-deal-adding-alzheimers-treatment-to-pipeline?utm_source=feed_news_all\u0026utm_medium=referral\u0026feed_item_type=news",
  "description": "",
  "author": "",
  "published": "Wed, 21 May 2025 20:39:26 -0400",
  "source": "https://seekingalpha.com/market_currents.xml",
  "categories": [
    "sny",
    "vigl"
  ],
  "byline": "Carl Surran",
  "length": 387,
  "excerpt": "Sanofi agreed to acquire clinical-stage biotechnology company Vigil Neuroscience for $470M in cash, potentially reaching $600M with milestone payments.",
  "siteName": "Seeking Alpha",
  "favicon": "https://seekingalpha.com/samw/static/images/favicon-192x192.png",
  "text": "HealthcareM\u0026APanama7/iStock Editorial via Getty ImagesSanofi (NASDAQ:SNY) said Wednesday it agreed to acquire clinical-stage biotechnology company Vigil Neuroscience (VIGL) for $470M in cash, potentially reaching $600M with milestone payments. Sanofi (NASDAQ:SNY) said it purchased Vigil (VIGL) for an upfront payment of $8/share, and VigilRecommended For YouMore Trending NewsSee More »",
  "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w750",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-test-id=\"grid-col-main\"\u003e\u003cdiv data-test-id=\"card-container\"\u003e\u003cheader\u003e\u003cdiv data-test-id=\"quick-links\"\u003e\u003cul\u003e\u003cli\u003e\u003ca data-test-id=\"theme-links-item\" href=\"https://seekingalpha.com/market-news/healthcare#source=section%3Amain_content%7Csection_asset%3Athemes%7Cbutton%3Ahealthcare%7Cfirst_level_url%3Anews\"\u003e\u003cspan\u003e\u003cspan\u003eHealthcare\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca data-test-id=\"theme-links-item\" href=\"https://seekingalpha.com/market-news/m-a#source=section%3Amain_content%7Csection_asset%3Athemes%7Cbutton%3Am-a%7Cfirst_level_url%3Anews\"\u003e\u003cspan\u003e\u003cspan\u003eM\u0026amp;A\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/li\u003e\u003c/ul\u003e\u003c/div\u003e\u003c/header\u003e\u003cdiv\u003e\u003cdiv data-test-id=\"content-container\"\u003e\u003cfigure contenteditable=\"false\" data-show-to-all=\"false\" data-type=\"getty-image\"\u003e\u003cpicture\u003e\u003cimg src=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w750\" sizes=\"(max-width: 768px) calc(100vw - 36px), (max-width: 1024px) calc(100vw - 132px), (max-width: 1200px) calc(66.6vw - 72px), 600px\" srcset=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w1536 1536w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w1280 1280w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w1080 1080w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w750 750w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w640 640w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w480 480w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w320 320w, https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg?io=getty-c-w240 240w\" alt=\"Night Sanofi office building in Berlin, Germany.\" width=\"5345px\" height=\"3271px\" data-caption=\"Panama7/iStock Editorial via Getty Images\" data-id=\"1125144281\" data-image-type=\"Getty\" data-original-src=\"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/medium_image_1125144281.jpg\" data-source=\"\" data-type=\"getty-image\"/\u003e\u003c/picture\u003e\u003cfigcaption data-type=\"getty-image\"\u003e\u003cp\u003ePanama7/iStock Editorial via Getty Images\u003c/p\u003e\u003c/figcaption\u003e\u003c/figure\u003e\u003cp\u003eSanofi (\u003cspan\u003eNASDAQ:\u003ca href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\"\u003eSNY\u003c/a\u003e\u003c/span\u003e) said Wednesday it \u003ca title=\"agreed to acquire\" href=\"https://seekingalpha.com/pr/20112910-press-release-sanofi-to-acquire-vigil-neuroscience-inc-adding-a-new-investigational-medicine\" target=\"_self\"\u003eagreed to acquire\u003c/a\u003e clinical-stage biotechnology company Vigil Neuroscience (\u003ca href=\"https://seekingalpha.com/symbol/VIGL\" title=\"Vigil Neuroscience, Inc.\"\u003eVIGL\u003c/a\u003e) for $470M in cash, potentially reaching $600M with milestone payments.\u003c/p\u003e \u003cp\u003eSanofi (\u003cspan\u003eNASDAQ:\u003ca href=\"https://seekingalpha.com/symbol/SNY\" title=\"Sanofi\"\u003eSNY\u003c/a\u003e\u003c/span\u003e) said it purchased Vigil (\u003ca href=\"https://seekingalpha.com/symbol/VIGL\" title=\"Vigil Neuroscience, Inc.\"\u003eVIGL\u003c/a\u003e) for an upfront payment of $8/share, and Vigil\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"recommended-section\"\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"recommended-for-you-card-title\"\u003eRecommended For You\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003csection data-test-id=\"trending-card-container\"\u003e\u003cdiv\u003e\u003cdiv\u003e\u003cp\u003e\u003ch2 data-test-id=\"trending-card-title\"\u003eMore \u003cspan id=\"trending-news\"\u003eTrending News\u003c/span\u003e\u003c/h2\u003e\u003c/p\u003e\u003c/div\u003e\u003cdiv data-test-id=\"post-skeleton\"\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv\u003e\u003cp\u003e\u003ca id=\"cardFooterSeeMore\" data-test-id=\"card-footer-link\" aria-labelledby=\"trending-news cardFooterSeeMore\" href=\"https://seekingalpha.com/market-news#source=first_level_url%3Anews%7Csection%3Amain_content%7Csection_asset%3Amore_trending_news%7Cbutton%3Amore\"\u003e\u003cspan\u003eSee More »\u003c/span\u003e\u003c/a\u003e\u003c/p\u003e\u003c/div\u003e\u003c/section\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "Less than 1 min",
  "publishedTime": "2025-05-22T00:39:26Z",
  "modifiedTime": null
}
